Bicara Therapeutics Inc.
BCAX
44 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 26 9:48 PM | Ivan HyepChief Financial Officer | Sale | 9,200 | $20.42 | $187.9K | 145,355(D) | View → |
| May 26, 2026 | May 26 8:02 PM | Raben David | Proposed Sale | 5,500 | $21.82 | $120.0K | — | View → |
| May 21, 2026 | May 21 8:02 PM | Hyep Ivan | Proposed Sale | 9,200 | $20.42 | $187.9K | — | View → |
| May 18, 2026 | May 20 8:07 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 15,000 | $20.04 | $300.6K | 362,152(D) | View → |
| May 15, 2026 | May 18 8:24 PM | Ryan CohlheppDirector, President and COO | Sale | 12,500 | $20.29 | $253.6K | 191,641(D) | View → |
| May 18, 2026 | May 18 8:18 PM | Mazumdar Claire | Proposed Sale | 15,000 | $20.92 | $313.8K | — | View → |
| May 15, 2026 | May 15 8:14 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $20.31 | $253.9K | — | View → |
| Apr 27, 2026 | Apr 28 11:49 PM | David RabenChief Medical Officer | Sale | 5,500 | $22.88 | $125.8K | 55,286(D) | View → |
| Apr 27, 2026 | Apr 27 8:09 PM | Raben David | Proposed Sale | 5,500 | $22.88 | $125.8K | — | View → |
| Apr 21, 2026 | Apr 22 8:53 PM | Ivan HyepChief Financial Officer | Sale | 9,200 | $23.00 | $211.6K | 145,355(D) | View → |
| Apr 21, 2026 | Apr 21 8:09 PM | Hyep Ivan | Proposed Sale | 9,200 | $23.18 | $213.2K | — | View → |
| Apr 20, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 15,000 | $23.61 | $354.1K | 362,152(D) | View → |
| Apr 20, 2026 | Apr 20 8:02 PM | Mazumdar Claire | Proposed Sale | 15,000 | $23.74 | $356.1K | — | View → |
| Apr 15, 2026 | Apr 17 8:55 PM | Ryan CohlheppDirector, President and COO | Sale | 12,500 | $23.01 | $287.6K | 196,141(D) | View → |
| Apr 15, 2026 | Apr 15 8:06 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $22.98 | $287.3K | — | View → |
| Mar 25, 2026 | Mar 26 11:21 PM | David RabenChief Medical Officer | Sale | 5,500 | $18.95 | $104.2K | 55,286(D) | View → |
| Mar 25, 2026 | Mar 25 8:01 PM | Raben David | Proposed Sale | 5,500 | $18.95 | $104.2K | — | View → |
| Mar 23, 2026 | Mar 24 11:45 PM | Ivan HyepChief Financial Officer | Sale | 9,200 | $18.52 | $170.3K | 145,355(D) | View → |
| Mar 23, 2026 | Mar 23 8:04 PM | Hyep Ivan | Proposed Sale | 9,200 | $18.60 | $171.1K | — | View → |
| Mar 20, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 1,596 | $18.95 | $30.2K | 339,392(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 200 | $3.79 | 69,213(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,200,000 | $0.0001 | 2,200,000(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 3,108 | $3.79 | 138,226(D) | View → |
| Feb 2, 2026 | Feb 4 9:38 PM | Ryan CohlheppDirector, President and COO | Grant/Award | 300,000 | $16.76 | 300,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:37 PM | Claire MazumdarDirector, Chief Executive Officer | Grant/Award | 450,000 | $16.76 | 450,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:36 PM | David RabenChief Medical Officer | Grant/Award | 100,000 | $16.76 | 100,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:35 PM | Ivan HyepChief Financial Officer | Grant/Award | 125,000 | $16.76 | 125,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:34 PM | Lara MeisnerChief Legal Officer | Grant/Award | 90,000 | $16.76 | 90,000(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Option Exercise | 1,882 | $3.79 | 65,462(D) | View → |
← Previous
Page 3 of 3